Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
3.200
-0.040 (-1.23%)
At close: Oct 15, 2026, 4:00 PM EDT
3.210
+0.010 (0.31%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $341.34 million as of October 15, 2026. It is the 17,404th most valuable company in the world and the 3,067th biggest in the United States. Its market cap has increased by 432.52% in one year.
Market Cap
341.34M
Enterprise Value
123.61M
1-Year Change
432.52%
Global Rank
Country Rank
#3,067 United States
Category
ChartMarket Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $341.34M, an increase of 503.08%. That is a compound annual growth rate of 17.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 341.34M | -3.63% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 363.33M |
| Fennec Pharmaceuticals | 362.95M |
| Orchestra BioMed Holdings | 345.00M |
| Turn Therapeutics | 344.35M |
| vTv Therapeutics | 342.80M |
| C4 Therapeutics | 342.01M |
| Prelude Therapeutics | 341.94M |
| Opus Genetics | 336.94M |